Loading...

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

BACKGROUND: Preclinical and preliminary clinical data indicate that ch14.18, a monoclonal antibody against the tumor-associated disialoganglioside GD2, has activity against neuroblastoma and that such activity is enhanced when ch14.18 is combined with granulocyte–macrophage colony-stimulating factor...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Main Authors: Yu, Alice L., Gilman, Andrew L., Ozkaynak, M. Fevzi, London, Wendy B., Kreissman, Susan G., Chen, Helen X., Smith, Malcolm, Anderson, Barry, Villablanca, Judith G., Matthay, Katherine K., Shimada, Hiro, Grupp, Stephan A., Seeger, Robert, Reynolds, C. Patrick, Buxton, Allen, Reisfeld, Ralph A., Gillies, Steven D., Cohn, Susan L., Maris, John M., Sondel, Paul M.
Format: Artigo
Sprog:Inglês
Udgivet: 2010
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3086629/
https://ncbi.nlm.nih.gov/pubmed/20879881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa0911123
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!